# Venture Investors Health Fund ## Posts - [From Daily Pills to Same-Day Relief: How Rivermark Medical is Redefining BPH Treatment](https://www.ventureinvestors.com/from-daily-pills-to-same-day-relief-how-rivermark-medical-is-redefining-bph-treatment/): Photo: Rivermark team members (from left to right)—Tristen Moors, Vice President Clinical Operations; Jaime Walkowiak, Executive Vice President of Operations; Greg Borecki, Vice President Market Development; Adam Kadlec, President & CEO; Andy Doraiswamy, Board Chairman For nearly 40 million men in the U.S., Benign Prostatic Hyperplasia (BPH) it is life-altering—impacting everything from sleep to confidence to quality of life. For decades, the treatment paradigm has remained largely unchanged: medication first, and if that fails, irreversible surgery. It’s a clinical limbo that leaves too many patients underserved. That’s where Rivermark Medical comes in. Co-founded by urologist and CEO Dr. Adam Kadlec, […] - [Venture Investors Health Fund Announces $80M Close of Seventh Fund to Transform Standard of Care in Healthcare](https://www.ventureinvestors.com/venture-investors-health-fund-announces-80m-close-of-seventh-fund-to-transform-standard-of-care-in-healthcare/): Madison, WI – September 10th 2025 – 9am CT – Venture Investors Health Fund (also known as “VI”) today announced the successful close of its seventh fund, raising $80 million to drive breakthrough healthcare innovations that aim to fundamentally change the standard of care. Based in the Midwest—home to world-class research universities and a thriving healthcare ecosystem—VI will continue to support early-stage companies that harness cutting-edge discoveries to deliver more precise, personalized care while improving access and reducing costs. VI is one of the Midwest’s longest-tenured healthcare-focused venture capital firms, with a 40-year track record under its belt. “Our seventh […] - [The Courage to Go First: A Patient’s Story of Histotripsy and the Power of HistoSonics](https://www.ventureinvestors.com/the-courage-to-go-first-a-patients-story-of-histotripsy-and-the-power-of-histosonics/) - [Sonic Scalpel: How HistoSonics’ Focused Ultrasound Is Redefining Tumor Treatment](https://www.ventureinvestors.com/sonic-scalpel-how-histosonics-focused-ultrasound-is-redefining-tumor-treatment/): A Conversation with Dr. Joan Vidal on Histotripsy’s Transformative Potential Across the world, solid tumors remain one of the most daunting challenges in patient care. Traditional treatment approaches—surgery, chemotherapy, and radiation—can often be invasive, imprecise, and taxing on patients, both physically and emotionally. For decades, clinicians and researchers have sought a new way forward: one that offers precision without incisions, efficacy without collateral damage, and healing without prolonged recovery. Enter HistoSonics. Born out of pioneering research at the University of Michigan, HistoSonics uses histotripsy—focused ultrasound pulses—to mechanically destroy and liquefy tumors at a microscopic level. Unlike thermal ablation or traditional […] - [No Wires, No Waitlists: Chris Fernandez of EnsoData on Making Sleep Diagnostics as Easy as Putting on a Watch](https://www.ventureinvestors.com/no-wires-no-waitlists-chris-fernandez-of-ensodata-on-making-sleep-diagnostics-as-easy-as-putting-on-a-watch/): Modern medicine has made staggering strides, yet one of its most fundamental building blocks... - [Rewriting the Autism Timeline: Dr. Ami Klin of EarliTec on Making Early Diagnosis Possible](https://www.ventureinvestors.com/rewriting-the-autism-timeline-dr-ami-klin-of-earlitec-on-making-early-diagnosis-possible/) - [30 Years of Impact: Lessons from Venture Investors Health Fund’s Early Bet on Third Wave Technologies (Acquired by Hologic, Inc.)](https://www.ventureinvestors.com/30-years-of-impact-lessons-from-venture-investors-health-funds-early-bet-on-third-wave-technologies-acquired-by-hologic-inc/): Pictured above: Panel discussion with John Neis, Lloyd Smith, Lance Fors, James Dahlberg, Kevin Conroy, and Maneesh Arora at Exact Sciences on Dec 2, 2024. Three decades ago, Venture Investors Health Fund (VI) made a bold move by backing Third Wave Technologies, a then-early-stage biotech company that went on to transform molecular diagnostics. The company developed groundbreaking DNA and RNA-based detection technologies, which played a crucial role in improving the early detection of diseases, particularly in infectious diseases and oncology. Their innovations helped set new standards in diagnostic accuracy, speed, and accessibility, ultimately shaping the broader field of personalized medicine. In 2008, […] - [Venture Investors Health Fund Backs Milwaukee Biotech Company Sanacor to Address Cardiometabolic Disease](https://www.ventureinvestors.com/venture-investors-health-fund-backs-milwaukee-biotech-company-sanacor-to-address-cardiometabolic-disease/): Madison, WI — January 9, 2025 — Venture Investors Health Fund (VI), a Midwest-based venture capital firm dedicated to advancing. - [Venture Investors Health Fund Promotes Jenni Le to Principal, Expanding Commitment to University Spinouts and Healthcare Innovation](https://www.ventureinvestors.com/venture-investors-health-fund-promotes-jenni-le-to-principal-expanding-commitment-to-university-spinouts-and-healthcare-innovation/): Photo: Jenni Le speaking at Venture Investors’ recent event, celebrating 30 years of investment. ## Pages - [ThirdWave Molecular Diagnostics](https://www.ventureinvestors.com/thirdwave-molecular-diagnostics/) - [NimbleGen](https://www.ventureinvestors.com/nimblegen/) - [Inviragen](https://www.ventureinvestors.com/inviragen/) - [Intralase](https://www.ventureinvestors.com/intralase/) - [Roger Ganser](https://www.ventureinvestors.com/roger-ganser-2/) - [Linda Olson](https://www.ventureinvestors.com/linda-olson-2/) - [Becky Hoerman](https://www.ventureinvestors.com/jim-adox-2-2/) - [David Arnstein](https://www.ventureinvestors.com/david-arnstein-2/) - [Jenni Le](https://www.ventureinvestors.com/jenni-le-2/) - [Shelly Lanning](https://www.ventureinvestors.com/shelly-lanning-2/) - [Joe Amaral, MD](https://www.ventureinvestors.com/joe-amaral-md/) - [John Neis](https://www.ventureinvestors.com/john-neis-2/) - [Paul Weiss](https://www.ventureinvestors.com/paul-weiss-2/) - [Scott Button](https://www.ventureinvestors.com/scott-button-2/) - [Jim Adox](https://www.ventureinvestors.com/jim-adox-2/) - [TEAM](https://www.ventureinvestors.com/team/) - [TomoTherapy](https://www.ventureinvestors.com/tomotherapy/) - [LenSx](https://www.ventureinvestors.com/lensx/) - [NeuWave Medical](https://www.ventureinvestors.com/neuwave-medical/) - [William Murphy](https://www.ventureinvestors.com/william-murphy/) - [Tim Bartholow](https://www.ventureinvestors.com/tim-bartholow/) - [Thomas Porter](https://www.ventureinvestors.com/thomas-porter/) - [T. Rockwell (Rock) Mackie](https://www.ventureinvestors.com/t-rockwell-rock-mackie/) - [Sundu Brahmasandra](https://www.ventureinvestors.com/sundu-brahmasandra/) - [Scott Cramer](https://www.ventureinvestors.com/scott-cramer/) - [Ron Sliwinski](https://www.ventureinvestors.com/ron-sliwinski/) - [Robert Miller](https://www.ventureinvestors.com/robert-miller/) - [Robert McMahon](https://www.ventureinvestors.com/robert-mcmahon/) - [Manuel Aivado](https://www.ventureinvestors.com/manuel-aivado/) - [Lloyd Smith](https://www.ventureinvestors.com/lloyd-smith/) - [Lisa Wipperman Heine](https://www.ventureinvestors.com/lisa-wipperman-heine/) - [Justin Mortara](https://www.ventureinvestors.com/justin-mortara/) - [Jeffrey Bahr](https://www.ventureinvestors.com/jeffrey-bahr/) - [Jeffrey Bailey](https://www.ventureinvestors.com/jeffrey-bailey/) - [Jeani Delagardele](https://www.ventureinvestors.com/jeani-delagardele/) - [James Dahlberg](https://www.ventureinvestors.com/james-dahlberg/) - [Ilke Panzer](https://www.ventureinvestors.com/ilke-panzer/) - [Herbert D. Aronow](https://www.ventureinvestors.com/herbert-d-aronow/) - [Fred Robertson](https://www.ventureinvestors.com/fred-robertson/) - [Fred Lee](https://www.ventureinvestors.com/fred-lee/) - [Erica J. Rogers](https://www.ventureinvestors.com/erica-j-rogers/) - [Cheryl Blanchard](https://www.ventureinvestors.com/cheryl-blanchard/) - [Bob Smith](https://www.ventureinvestors.com/bob-smith/) - [Insights](https://www.ventureinvestors.com/insights/) - [Press](https://www.ventureinvestors.com/press/) - [CHALLENGE NETWORK](https://www.ventureinvestors.com/challenge-network/) - [Contact](https://www.ventureinvestors.com/contact/) - [Our Portfolio
](https://www.ventureinvestors.com/our-portfolio/) - [About Us](https://www.ventureinvestors.com/about-us/) - [Home](https://www.ventureinvestors.com/) [comment]: # (Generated by Hostinger Tools Plugin)